Ari Zimran: Clinical Trials

1 trial sponsored by Ari Zimran, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Ari Zimran: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease
Elelyso - Gaucher Disease, Type 3
Phase 4CompletedAri Zimran142020-11-202024-12-17

Conditions studied

Gaucher Disease (1)

Interventions

taliglucerase alfa (1)

Countries

India (1)  ·  Israel (1)  ·  Turkey (Türkiye) (1)